NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
7.42
+0.29 (4.07%)
At close: Jun 6, 2025, 4:00 PM
7.29
-0.13 (-1.74%)
After-hours: Jun 6, 2025, 7:59 PM EDT
NeoGenomics Market Cap
NeoGenomics has a market cap or net worth of $954.91 million as of June 6, 2025. Its market cap has decreased by -49.41% in one year.
Market Cap
954.91M
Enterprise Value
1.20B
1-Year Change
-49.41%
Ranking
Category
Stock Price
$7.42
Market Cap Chart
Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $954.91M, an increase of 11,987.51%. That is a compound annual growth rate of 25.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 6, 2025 | 954.90M | -54.86% |
Dec 31, 2024 | 2.12B | 2.57% |
Dec 29, 2023 | 2.06B | 76.73% |
Dec 30, 2022 | 1.17B | -72.22% |
Dec 31, 2021 | 4.20B | -29.72% |
Dec 31, 2020 | 5.98B | 95.74% |
Dec 31, 2019 | 3.05B | 160.37% |
Dec 31, 2018 | 1.17B | 64.64% |
Dec 29, 2017 | 712.40M | 5.87% |
Dec 30, 2016 | 672.90M | 41.66% |
Dec 31, 2015 | 475.00M | 89.92% |
Dec 31, 2014 | 250.10M | 41.06% |
Dec 31, 2013 | 177.30M | 57.88% |
Dec 31, 2012 | 112.30M | 85.62% |
Dec 30, 2011 | 60.50M | 24.49% |
Dec 31, 2010 | 48.60M | -12.90% |
Dec 31, 2009 | 55.80M | 189.12% |
Dec 31, 2008 | 19.30M | -43.07% |
Dec 31, 2007 | 33.90M | -16.30% |
Dec 29, 2006 | 40.50M | 841.86% |
Dec 30, 2005 | 4.30M | -20.37% |
Dec 31, 2004 | 5.40M | -31.65% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 687.38B |
Johnson & Johnson | 369.72B |
AbbVie | 331.15B |
Novo Nordisk | 324.15B |
UnitedHealth Group | 268.37B |
Abbott Laboratories | 233.03B |
Novartis AG | 230.96B |
AstraZeneca | 225.55B |